Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylphenidate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Focalin 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
doxapramhydrochlorid 20 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 10 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 10 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 20 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 27 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 54 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 30 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 40 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 2 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and caffeine and cinnamedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing caffeine and paracetamol and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing buffered aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
ergotamin + caffein |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 72 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
Psychostimulant (substance) |
Is a |
True |
Stimulant (substance) |
Inferred relationship |
Some |
|
Stimulant dependence |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Stimulant drug therapy for attention deficit hyperactivity disorder |
Direct substance |
True |
Stimulant (substance) |
Inferred relationship |
Some |
3 |
Stimulant therapy |
Direct substance |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Harmful pattern of use of stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Disorder caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Delirium caused by stimulant |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Psychotic disorder caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Mood disorder caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Anxiety disorder caused by stimulant |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Sleep disorder caused by stimulant |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Impulse control disorder caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Sexual dysfunction caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
2 |
Psychotic disorder with hallucinations caused by stimulant |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Intoxication caused by stimulant (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Episode of harmful use of stimulant |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user. |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
Sleep disorder due to stimulant dependence (disorder) |
Causative agent |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |